FDA Consumer Health Product Recalls For May 4-25, 2016
This article was originally published in The Tan Sheet
Executive Summary
Recalls reported by FDA for OTC drugs, nutritionals and personal care products.
You may also be interested in...
Keystone Labs Court-Ordered To Halt OTC Drug Manufacturing; Cosmetics Not Affected, It Says
Keystone Labs agrees to cease manufacturing OTC drugs following a 2013 FDA warning letter and repeated GMP violations noted during inspections, including failure to investigate sources of contamination. Firm suggests it will continue making cosmetic hair- and skin-care formulas while outsourcing OTC product manufacturing.
Keystone Labs Keeps OTC Drugs In Plans After Court Orders Manufacturing Halt
Keystone Labs agrees to cease manufacturing OTC drugs after repeat GMP violations following a 2013 FDA warning letter, including failure to investigate sources of contamination. Firm says it informed FDA it would outsource OTC product manufacturing and continue making hair and skin care cosmetic formulas.
Keystone Labs Keeps OTC Drugs In Plans After Court Orders Manufacturing Halt
Keystone Labs agrees to cease manufacturing OTC drugs after repeat GMP violations following a 2013 FDA warning letter, including failure to investigate sources of contamination. Firm says it informed FDA it would outsource OTC product manufacturing and continue making hair and skin care cosmetic formulas.